http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13488310

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 2381
issn 2211-1247
issueIdentifier 9
pageRange 2367-2381
publicationName Cell Reports
startingPage 2367
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5060caf1dbb157b635b5050a4e721a78
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a881bc874cdba44d3dfc1e8abbbeace7
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ccf7478ee4e31343854a322874f29b09
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_30e09241fb81478aab8e91bd44b92c4a
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_afb669af4a1962244e68b8dc8ffcad7d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1f2cab120cebbba174d5c784dcfba7ea
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7a1c32793a20563fa58f3bedd947b59b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bf9c8e5c69ff222e3ee2ff0fc4d2b289
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a144bd14c471aa453e3323eefac0d893
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0352fa9dbf5677f98c9a97bb83d9d515
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8990eaf11b469f43462c30ceeb3fad6a
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b1c54dd96d7a328232c85e2e2469cc39
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f44e02fcf9fa27484f2fa88838529c69
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8228aba572b4af9b66e6d2c1c35d1b03
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_36d99a0ca4f57789efe88b1b1e09d070
bibliographicCitation Johnson SF, Cruz C, Greifenberg AK, Dust S, Stover DG, Chi D, Primack B, Cao S, Bernhardy AJ, Coulson R, Lazaro J, Kochupurakkal B, Sun H, Unitt C, Moreau LA, Sarosiek KA, Scaltriti M, Juric D, Baselga J, Richardson AL, Rodig SJ, D’Andrea AD, Balmaña J, Johnson N, Geyer M, Serra V, Lim E, Shapiro GI. CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer. Cell Reports. 2016 Nov;17(9):2367–81. doi: 10.1016/j.celrep.2016.10.077.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_521a648e6779fe6de4306fadbeb1ca81
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10a10eaa6d33a00728ecfcf073a8cbbb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddbb9b750e0eb25699eeee7377bfb7f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c630f67d9ed0513ffe23437ed4f9f8ba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9862375c72a29819e06887bbfdb9feac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bfac73fe53891888ae5537cc33ed19c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ed8c969bc4c7ce62d4ab7feba6b0166
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f261cc72979a8f93ed9295de43115b4f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f36c409f3124eb7513c0edaf2fc1bced
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0762-6415
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6673d701295d3459270a711c96103ebc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6620-1065
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f22ec524f9a82948b2e8553baba62145
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c60daa6482ff5039267945829f0be6fb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8065-8838
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_010a54bab535f45cddd04bb349388a29
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f77779e634fa90ce959acaa36830a94
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_352028ef006262b21fc7b2d5fd208e0d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71fc27c25bed74a3e5e530bacab9c02b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cea2190eb14f8b2e44bfb4558c7bca9e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6946f35bf446cca7aa21fe3d2a17f30c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b804917e4f55719573a3e0def971a2c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdf4d88af5b90761b39da8f774efb334
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1ff8df666ae88e62a1c8122c79f95fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66736ab9824e82f66c5200ddc3e57758
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c873640518537509bb52c133f1a8f435
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_349e76b6933c18beb4c1606a72636730
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df012bfe1f05f292594505ba14712d0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7718-5002
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61b42b1f428d3edf617b2daf7386f454
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daaf2d7203589f4696bf079376f8842c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b90754be72e47126bfc43ee6512eecfd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4908-0091
date 2016-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC5176643
https://doi.org/10.1016/j.celrep.2016.10.077
https://pubmed.ncbi.nlm.nih.gov/27880910
isPartOf https://portal.issn.org/resource/ISSN/2211-1247
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39703
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
discusses http://id.nlm.nih.gov/mesh/M0018234
http://id.nlm.nih.gov/mesh/M0028197
http://id.nlm.nih.gov/mesh/M0028488
http://id.nlm.nih.gov/mesh/M0005453
http://id.nlm.nih.gov/mesh/M0406100
http://id.nlm.nih.gov/mesh/M0475257
http://id.nlm.nih.gov/mesh/M0551967
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0415153
http://id.nlm.nih.gov/mesh/M0011239
http://id.nlm.nih.gov/mesh/M000601132
http://id.nlm.nih.gov/mesh/M0028758
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D019313Q000378
http://id.nlm.nih.gov/mesh/D009154Q000235
http://id.nlm.nih.gov/mesh/D064726Q000473
http://id.nlm.nih.gov/mesh/D019008Q000187
http://id.nlm.nih.gov/mesh/D018844Q000037
http://id.nlm.nih.gov/mesh/D000067856Q000494
http://id.nlm.nih.gov/mesh/D064726Q000201
hasSubjectTerm http://id.nlm.nih.gov/mesh/D019086Q000494
http://id.nlm.nih.gov/mesh/D055786
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D000595
http://id.nlm.nih.gov/mesh/D004260Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D007212
http://id.nlm.nih.gov/mesh/D018844Q000378
http://id.nlm.nih.gov/mesh/D003497
http://id.nlm.nih.gov/mesh/D004249Q000235
http://id.nlm.nih.gov/mesh/D023041
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D034741Q000378
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D059765Q000187
http://id.nlm.nih.gov/mesh/D047428Q000494
http://id.nlm.nih.gov/mesh/D018844Q000737
http://id.nlm.nih.gov/mesh/D014158Q000187
http://id.nlm.nih.gov/mesh/D015972Q000187
http://id.nlm.nih.gov/mesh/D064726Q000235
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D011726Q000494
http://id.nlm.nih.gov/mesh/D019313Q000235
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46926350
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_533622b82f51bc5431a771c088f3bdd9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.4.2.30
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6f7ded7dee3b6f983695e5878f2cbcca
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8937
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_467b750f9a6073f1098d1aa6270e135d
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_effabf75f87a02358f0a8868edaf2c9f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5f8f19d61252fdce5cae1f415ad035b2
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134223378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376073396

Total number of triples: 121.